Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Severe pelvic pain during menstrual periods is the main symptom of endometriosis. Other symptoms include excessive bleeding ...

With a significant rise in endometriosis cases among women aged 20-40, early intervention and awareness are crucial to reduce ...

There is a 10 per cent rise in endometriosis cases among women, with one in 10 women getting diagnosed with the condition per ...

Endometriosis, which often goes undiagnosed for years, can severely impact women’s quality of life and fertility if left ...

Endometriosis can be a brake on women's careers Endometriosis is a chronic, inflammatory, hormone-dependent gynecological disease that affects around 10% of women of childbearing age. The main ...

A report reveals endometriosis leads to lower wages and job loss for women, highlighting workplace stigma and causing uproar ...

The Albanese government will announce half a billion dollars in women’s health investments, highlighting improved access to ...

The Albanese government has announced half a billion in funding for women's health reforms in Australia, so what's the real ...

Medically reviewed by Laura Young Endometriosis occurs when tissue that lines the uterus (womb) grows elsewhere, usually on ...

A new study of Australians living with chronic physical health conditions has found family members and doctors who dismiss their experiences cause ...

Women's Health in the South East (WHISE) applauds the Australian Government's $573.3 million investment in women's health, which will improve access ...